Leukemia arising out of paroxysmal nocturnal hemoglobinuria

John W. Harris, Robert Koscick, Hillard M. Lazarus, James R. Eshleman, M. Edward Medof

Research output: Contribution to journalArticle

Abstract

In paroxysmal nocturnal hemoglobinuria (PNH), one or more hematopoietic stem cells that are defective in GPI anchor assembly as a result of mutation in the PIG-A gene preferentially expand in the bone marrow and give rise to peripheral blood elements that are deficient in GPI anchored protein expression. According to current concepts, 5-15% of PNH patients develop leukocyte dyscrasias which invariably are acute myelogenous leukemia (AML). In this review, the literature from 1962 to the present is analyzed regarding the type of leukocyte dyscrasia, incidence, and cytogenetic features of the abnormal cells that have been reported. Among a total of 119 cases that are well-documented, 104 myeloid dyscrasias involving several categories in addition to AML, as well as 15 lymphoid dyscrasias are described. Of 1760 patients in 15 series that contain 20 or more patients, 16 (1%) are reported as having developed 'acute leukemia.' However, of 288 listed as having died, 13 (5%) are recorded as having had 'acute leukemia.' In 32 of the patients with hematological dyscrasias where karyotypes were analyzed, 7 were found to be normal and 25 found to harbor various alterations with the +8 abnormality present in 8. In 5 of 7 instances evidence indicates that the dyscratic cell arises from the PNH clone. Processes potentially involved in the evolution of the dyscratic cells from PNH clones are discussed.

Original languageEnglish (US)
Pages (from-to)401-426
Number of pages26
JournalLeukemia and Lymphoma
Volume32
Issue number5-6
DOIs
StatePublished - Jan 1 1999

    Fingerprint

Keywords

  • Leukemia AML
  • PNH
  • Paroxysmal nocturnal hemoglobinuria

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this